scholarly journals Determinants of Slow Flow in Percutaneous Coronary Intervention to the Culprit Lesion of Non-ST Elevation Myocardial Infarction

2018 ◽  
Vol 59 (6) ◽  
pp. 1237-1245 ◽  
Author(s):  
Yusuke Watanabe ◽  
Kenichi Sakakura ◽  
Yousuke Taniguchi ◽  
Kei Yamamoto ◽  
Hiroshi Wada ◽  
...  
Open Heart ◽  
2021 ◽  
Vol 8 (2) ◽  
pp. e001763
Author(s):  
Matthew E Li Kam Wa ◽  
Kalpa De Silva ◽  
Carlos Collet ◽  
Divaka Perera

How do we reduce cardiac death and myocardial infarction by percutaneous coronary intervention (PCI) in coronary heart disease? Although the interventional community continues to grapple with this question in stable angina, the benefits of PCI for non-culprit lesions found at ST-elevation myocardial infarction are established. Is it then wishful thinking that an index developed in stable coronary disease, for identifying lesions capable of causing ischaemia will show an incremental benefit over angiographically guided non-culprit PCI? This is the question posed by the recently published FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction (FLOWER-MI) trial. We examine the trial design and results; ask if there is any relationship between the baseline physiological significance of a non-culprit lesion and vulnerability to future myocardial infarction; and consider if more sophisticated methods can help guide or defer non-culprit revascularisation.


Sign in / Sign up

Export Citation Format

Share Document